|
S. Michael Imperiale Jr. M.D. joined Hana as Vice President Clinical Research Operations in August 2007. Dr. Imperiale is responsible for all aspects of clinical operations related to the development of Hana’s drug candidates. Prior to joining Hana Dr. Imperiale held the position of Senior Director of Medical Sciences at Nuvelo Inc. where he was the clinical lead and strategist of the oncology program and managed the team of Medical Science Liaisons. Prior to Nuvelo Dr. Imperiale was Director Clinical Trials Development at Exelixis Inc. where he was responsible for U.S. Food and Drug Administration clinical filings building external investigator relationships and oversight of oncology and nephrology clinical trial programs. Dr. Imperiale has also previously worked at InterMune Inc. and Boehringer-Ingelheim Pharmaceutical Corporation. He earned a Doctor of Medicine from Hahnemann University School of Medicine and a Bachelor of Arts degree in Psychology from Villanova University. | 